Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 105

    1.

    When to base clinical policies on observational versus randomized trial data.

    Hornberger J, Wrone E.

    Ann Intern Med. 1997 Oct 15;127(8 Pt 2):697-703. Review.PMID: 9382383 [PubMed - indexed for MEDLINE]Related articles

    2.

    Clinical and economic outcomes assessment in nuclear cardiology.

    Shaw LJ, Miller DD, Berman DS, Hachamovitch R.

    Q J Nucl Med. 2000 Jun;44(2):138-52. Review.PMID: 10967624 [PubMed - indexed for MEDLINE]Related articles

    3.

    A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.

    Forbes C, Shirran L, Bagnall AM, Duffy S, ter Riet G.

    Health Technol Assess. 2001;5(28):1-110. Review.PMID: 11701100 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Evidence-based medicine and health economics: a case study of end stage renal disease.

    Vale L, Donaldson C, Daly C, Campbell M, Cody J, Grant A, Khan I, Lawrence P, Wallace S, MacLeod A.

    Health Econ. 2000 Jun;9(4):337-51.PMID: 10862077 [PubMed - indexed for MEDLINE]Related articles

    5.

    What have we learned from the current trials?

    Abbott KC, Bakris GL.

    Med Clin North Am. 2004 Jan;88(1):189-207. Review.PMID: 14871059 [PubMed - indexed for MEDLINE]Related articles

    6.

    Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.

    Wilby J, Kainth A, Hawkins N, Epstein D, McIntosh H, McDaid C, Mason A, Golder S, O'Meara S, Sculpher M, Drummond M, Forbes C.

    Health Technol Assess. 2005 Apr;9(15):1-157, iii-iv. Review.PMID: 15842952 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Rating the strength of scientific evidence: relevance for quality improvement programs.

    Lohr KN.

    Int J Qual Health Care. 2004 Feb;16(1):9-18.PMID: 15020556 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.

    MacLeod A, Daly C, Khan I, Vale L, Campbell M, Wallace S, Cody J, Donaldson C, Grant A.

    Cochrane Database Syst Rev. 2001;(3):CD003234. Review. Update in: Cochrane Database Syst Rev. 2005;(3):CD003234. PMID: 11687058 [PubMed - indexed for MEDLINE]Related articles

    9.

    Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.

    Main C, Bojke L, Griffin S, Norman G, Barbieri M, Mather L, Stark D, Palmer S, Riemsma R.

    Health Technol Assess. 2006 Mar;10(9):1-132. iii-iv. Review.PMID: 16545208 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    How to develop cost-conscious guidelines.

    Eccles M, Mason J.

    Health Technol Assess. 2001;5(16):1-69. Review.PMID: 11427188 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    The cost of knowledge in nephrology and the importance of clinical databases.

    Zoccali C.

    J Nephrol. 2000 Jan-Feb;13(1):43-5.PMID: 10720213 [PubMed - indexed for MEDLINE]Related articles

    12.

    Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.

    Williams C, Brunskill S, Altman D, Briggs A, Campbell H, Clarke M, Glanville J, Gray A, Harris A, Johnston K, Lodge M.

    Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. Review.PMID: 16959170 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    The cost-benefit of a randomized trial to a health care organization.

    Hornberger J, Eghtesady P.

    Control Clin Trials. 1998 Apr;19(2):198-211. Review.PMID: 9551284 [PubMed - indexed for MEDLINE]Related articles

    14.

    [Controlled randomized clinical trials]

    Jaillon P.

    Bull Acad Natl Med. 2007 Apr-May;191(4-5):739-56; discussion 756-8. French. PMID: 18225427 [PubMed - indexed for MEDLINE]Related articles

    15.

    Extended-interval aminoglycoside administration for children: a meta-analysis.

    Contopoulos-Ioannidis DG, Giotis ND, Baliatsa DV, Ioannidis JP.

    Pediatrics. 2004 Jul;114(1):e111-8.PMID: 15231982 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Designing a cost-effective clinical trial.

    Hornberger JC, Brown BW Jr, Halpern J.

    Stat Med. 1995 Oct 30;14(20):2249-59.PMID: 8552901 [PubMed - indexed for MEDLINE]Related articles

    17.

    Policy and program analysis using administrative databases.

    Ray WA.

    Ann Intern Med. 1997 Oct 15;127(8 Pt 2):712-8. Review.PMID: 9382385 [PubMed - indexed for MEDLINE]Related articles

    18.

    Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials.

    Bazzano LA, Reynolds K, Holder KN, He J.

    JAMA. 2006 Dec 13;296(22):2720-6. Erratum in: JAMA. 2007 Mar 7;297(9):952. PMID: 17164458 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.

    Shepherd J, Jones J, Frampton GK, Tanajewski L, Turner D, Price A.

    Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. Review.PMID: 18547499 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Evidence-based medicine. Interpreting studies and setting policy.

    Woolf SH, George JN.

    Hematol Oncol Clin North Am. 2000 Aug;14(4):761-84. Review.PMID: 10949772 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data